Prostatic Abscess and Cysts

Prostatic abscess and cysts are pathological cavitary lesions of the canine prostate gland, characterized by the accumulation of purulent exudate (abscess) or sterile fluid (cyst) within the prostatic parenchyma. These conditions are typically sequelae of benign prostatic hyperplasia (BPH) and are most commonly diagnosed in intact male dogs. Prostatic abscesses represent a severe, potentially life-threatening infection of the prostate, often associated with systemic illness, whereas prostatic cysts may be sterile or become secondarily infected. Surgical management is frequently required for definitive treatment, especially for abscesses, and may involve drainage techniques, marsupialization, or partial/total prostatectomy. The disease is less common in cats, where prostatic disease is rare. Accurate diagnosis and timely surgical intervention are critical to prevent complications such as sepsis, peritonitis, and urethral obstruction.

The primary etiology of prostatic abscess and cysts is benign prostatic hyperplasia (BPH), which occurs in intact male dogs due to chronic androgen stimulation. BPH leads to the formation of multiple parenchymal cysts, which can become infected, resulting in abscessation. Bacterial infection is typically ascending from the urethra, with common pathogens including Escherichia coli, Staphylococcus spp., Streptococcus spp., Klebsiella spp., Proteus spp., and Pseudomonas spp. Hematogenous spread is less common. Other contributing factors include urinary tract infections, prostatic neoplasia (which can predispose to cyst formation), and iatrogenic causes such as urethral catheterization or prostatic biopsy. In some cases, congenital prostatic cysts (e.g., utricle cysts) may be present, which can become infected. The exact cellular mechanisms involve bacterial colonization of the prostatic ducts, inflammation, and necrosis, leading to the formation of abscess cavities. Hormonal factors, such as estrogen imbalance, may also contribute to squamous metaplasia and cyst formation.

Prostatic abscess and cysts are predominantly diseases of intact male dogs, with a higher incidence in middle-aged to older dogs (typically >6 years). Breeds such as the Doberman Pinscher, German Shepherd, and Boxer may be overrepresented, though any breed can be affected. The condition is rare in neutered males, as BPH is androgen-dependent. Cats are rarely affected due to the rudimentary nature of the feline prostate. The exact incidence is not well-documented, but prostatic disease is a common clinical problem in intact male dogs, with BPH affecting over 80% of intact males by 6 years of age. Abscessation occurs in a subset of these cases, often when BPH is left untreated or when urinary tract infections are recurrent. Working dogs and those with high testosterone levels may be at increased risk. There is no known genetic predisposition, but conformational factors such as a long urethra may increase the risk of ascending infection.

The pathophysiology begins with benign prostatic hyperplasia (BPH), where androgen-driven proliferation of prostatic epithelial and stromal cells leads to glandular enlargement and the formation of multiple cysts. These cysts are initially sterile and contain serous fluid. Bacterial infection, typically ascending from the urethra, can colonize the prostatic ducts and cysts, leading to suppurative inflammation. The bacteria produce toxins and enzymes that cause tissue necrosis, resulting in the formation of abscess cavities filled with purulent exudate. The abscesses can expand, causing pressure necrosis of surrounding prostatic tissue and potentially rupturing into the peritoneal cavity, leading to septic peritonitis. The infection can also spread via the bloodstream, causing bacteremia and sepsis. The enlarged prostate can compress the urethra, causing dysuria and urinary obstruction. Chronic inflammation may lead to fibrosis and further impairment of prostatic function. In some cases, the abscesses may become walled off, forming chronic abscesses with thick capsules. The systemic inflammatory response can lead to fever, leukocytosis, and other signs of sepsis.

Intrinsic risk factors include intact male status, increasing age (due to BPH), and breed predisposition (e.g., Doberman Pinschers). Genetic factors may influence the severity of BPH. Metabolic conditions such as diabetes mellitus may increase susceptibility to infection. Extrinsic factors include recurrent urinary tract infections, urethral catheterization, and prior prostatic surgery. Trauma to the perineal region may also predispose to prostatic injury and infection. Poor hygiene and environmental factors that increase the risk of ascending infection are also relevant. Additionally, the use of immunosuppressive drugs (e.g., corticosteroids) can increase the risk of infection. Obesity may be a contributing factor due to increased abdominal pressure and urinary stasis.

Clinical signs vary depending on the severity and whether the lesion is an abscess or cyst. Common signs include tenesmus (straining to defecate), dysuria (difficulty urinating), hematuria, and purulent urethral discharge. Dogs may exhibit a stiff gait, caudal abdominal pain, and reluctance to sit. Systemic signs of infection, such as fever, lethargy, anorexia, and vomiting, are common with abscesses. On physical examination, an enlarged, painful prostate may be palpated per rectum. In cases of abscess rupture, acute signs of peritonitis, including severe abdominal pain, shock, and collapse, may be present. Chronic cases may present with weight loss and recurrent urinary tract infections. In some instances, the condition may be asymptomatic, especially with sterile cysts.

Differential diagnoses include benign prostatic hyperplasia (BPH), prostatic neoplasia (adenocarcinoma, transitional cell carcinoma), prostatitis (acute and chronic), prostatic cysts (paraprostatic cysts, utricle cysts), and urinary tract infections. BPH typically presents with symmetric prostatomegaly without systemic signs. Prostatic neoplasia is more common in older dogs and may be associated with bony metastasis, and cytology/histopathology is definitive. Acute prostatitis may present with similar signs but without discrete abscess formation on imaging. Paraprostatic cysts are located adjacent to the prostate and may be congenital. Urethral obstruction due to other causes, such as urolithiasis, should also be considered. Other differentials include perineal hernia, rectal diverticulum, and lower urinary tract disease. Definitive diagnosis requires imaging and cytology/culture.

The diagnostic workup begins with a thorough history and physical examination, including digital rectal palpation of the prostate. If prostatic disease is suspected, the following steps are recommended: 1) Complete blood count, serum biochemistry, and urinalysis with urine culture. 2) Abdominal radiography to assess prostatic size and shape, and to rule out other causes. 3) Abdominal ultrasonography to evaluate prostatic parenchyma, identify cysts or abscesses, and guide fine-needle aspiration. 4) Fine-needle aspiration of prostatic fluid or cystic content for cytology and bacterial culture. 5) If neoplasia is suspected, prostatic biopsy may be performed. 6) Advanced imaging such as CT or MRI may be indicated for surgical planning, especially to assess the extent of the lesion and involvement of surrounding structures. 7) In cases of suspected rupture, abdominocentesis or diagnostic peritoneal lavage may be performed. The algorithm should be tailored to the patient's stability, with emergency stabilization if sepsis is present.

Hematology may reveal leukocytosis with a left shift, and in severe cases, neutropenia. Serum biochemistry may show elevated liver enzymes due to sepsis, and azotemia if urinary obstruction is present. Urinalysis often reveals hematuria, pyuria, and bacteriuria. Urine culture is essential to identify the causative organism and guide antibiotic therapy. Prostatic fluid cytology, obtained via ejaculation or fine-needle aspiration, may show degenerate neutrophils, bacteria, and macrophages. Culture of prostatic fluid or abscess content is critical. Coagulation panel (PT/aPTT) may be prolonged in sepsis. Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) may be elevated. Blood gas analysis may reveal metabolic acidosis in septic patients.

Radiography: Abdominal radiographs may show an enlarged prostate, with a soft tissue mass in the caudal abdomen. In some cases, mineralization may be seen in chronic abscesses. Radiographs can also identify free abdominal fluid if rupture has occurred. Ultrasonography: This is the imaging modality of choice. Prostatic abscesses appear as cavitary lesions with mixed echogenicity, often with thick walls and internal debris. Cysts appear as anechoic, well-defined structures. Ultrasound can guide aspiration for cytology and culture. CT: Computed tomography provides detailed cross-sectional imaging and is excellent for surgical planning, especially for assessing the extent of the lesion and its relationship to the urethra. MRI: Magnetic resonance imaging offers superior soft tissue contrast and may be useful in complex cases, but is less commonly used. Urethrography or retrograde contrast studies may be used to assess urethral involvement. Angiography is rarely needed.

Cytology of prostatic fluid or aspirated cyst/abscess content typically reveals suppurative inflammation with degenerate neutrophils, macrophages, and intracellular or extracellular bacteria. The presence of bacteria on cytology is highly suggestive of abscess. Histopathology of prostatic tissue, obtained via biopsy, is essential to differentiate abscess/cyst from neoplasia. In abscesses, there is necrosis, neutrophilic infiltration, and fibrosis. Cysts are lined by cuboidal or columnar epithelium. Special stains, such as Gram stain, can help identify bacterial types. If neoplasia is present, histopathology will reveal malignant cells, and grading may be performed. Surgical margins should be evaluated if a prostatectomy is performed.

Treatment of prostatic abscess and cysts typically involves a combination of medical and surgical management. Medical therapy includes antibiotics based on culture and sensitivity, and in some cases, androgen deprivation (e.g., castration) to reduce prostatic size. However, surgical intervention is often necessary for definitive treatment of abscesses. Surgical options include: 1) Ultrasound-guided percutaneous drainage with or without placement of a drainage catheter. This is minimally invasive but may be associated with a high recurrence rate. 2) Marsupialization of the abscess cavity to the abdominal wall, which allows ongoing drainage. This is a salvage procedure with significant morbidity. 3) Partial prostatectomy, which involves removal of the affected prostatic tissue while preserving the urethra. This is the preferred surgical approach for localized abscesses. 4) Total prostatectomy, which is reserved for severe, diffuse disease or neoplasia, but is associated with high morbidity (urinary incontinence). 5) Omentalization of the abscess cavity, which involves placing a pedicle of omentum into the cavity to promote drainage and healing. This technique has gained popularity due to its simplicity and low complication rate. Preoperative stabilization includes intravenous fluids, broad-spectrum antibiotics, and pain management. Postoperative care includes continued antibiotics, analgesia, and monitoring for complications such as urinary incontinence, urethral obstruction, and recurrence.

The prognosis for prostatic abscess and cysts is generally good with appropriate surgical and medical management, especially if the condition is diagnosed early and treated aggressively. The success rate for surgical treatment (e.g., omentalization or partial prostatectomy) is high, with resolution of clinical signs in most cases. However, complications such as urinary incontinence (especially after total prostatectomy), recurrence of abscessation, and sepsis can negatively impact the outcome. The prognosis is guarded if the abscess has ruptured, leading to septic peritonitis, or if there is concurrent prostatic neoplasia. Negative prognostic indicators include severe systemic illness, delayed treatment, and the presence of multidrug-resistant bacteria. With appropriate care, many dogs can achieve a good quality of life, but long-term monitoring is required.

Postoperative follow-up is crucial. Patients should be re-evaluated at 2 weeks, 6 weeks, and 3 months after surgery. Suture removal is typically at 10-14 days. Serial ultrasound examinations are recommended at 4, 8, and 12 weeks to assess resolution of the abscess/cyst and to monitor for recurrence. Urine cultures should be repeated at 2 and 6 weeks postoperatively to ensure eradication of infection. Restricted activity is advised for 4-6 weeks to allow healing. Physical rehabilitation may be beneficial to maintain muscle mass and joint health. Long-term monitoring includes regular physical examinations, ultrasound, and urinalysis every 6-12 months. If castration was performed, the owner should be advised on the benefits of neutering. Any signs of recurrence, such as dysuria or tenesmus, should prompt immediate evaluation.

Pearls: 1) Always perform a digital rectal examination in any intact male dog with lower urinary tract signs. 2) Use ultrasound-guided aspiration to obtain samples for culture before starting antibiotics. 3) Consider omentalization as a simple and effective surgical technique for prostatic abscesses. 4) Ensure adequate drainage of the abscess cavity to prevent recurrence. 5) Castration is an important adjunctive therapy to reduce prostatic size and prevent recurrence. Pitfalls: 1) Avoid percutaneous drainage alone, as it has a high recurrence rate. 2) Do not delay surgery in cases of abscess rupture; immediate stabilization and exploratory laparotomy are required. 3) Be cautious with total prostatectomy due to the high risk of urinary incontinence. 4) Do not rely solely on antibiotics; surgical drainage is essential. 5) Monitor for urethral obstruction postoperatively, as swelling may cause obstruction.

Perioperative antimicrobial therapy: For prophylaxis, cefazolin (22 mg/kg IV) administered 30 minutes before incision and repeated every 90 minutes during surgery. Postoperatively, continue with amoxicillin-clavulanate (13.75 mg/kg PO q12h) or enrofloxacin (10 mg/kg PO q24h) based on culture and sensitivity. For septic patients, initiate broad-spectrum antibiotics such as ampicillin (22 mg/kg IV q8h) and enrofloxacin (10 mg/kg IV q24h) or a combination of a beta-lactam and an aminoglycoside (e.g., gentamicin 6 mg/kg IV q24h, with careful monitoring of renal function). Analgesia: Preoperative opioids such as hydromorphone (0.05-0.1 mg/kg IV) or methadone (0.1-0.2 mg/kg IV). Postoperative pain management may include a fentanyl CRI (2-5 mcg/kg/hr IV) for 24 hours, followed by oral tramadol (2-5 mg/kg PO q8-12h) and a NSAID such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) for 3-5 days, with caution in patients with renal or hepatic disease. Local anesthesia: A lumbosacral epidural with morphine (0.1 mg/kg) and bupivacaine (0.5-1 mg/kg) can provide excellent analgesia. Muscle relaxants are not typically needed. Chondroprotectants are not relevant. Adjust dosages in patients with renal impairment, especially for aminoglycosides and NSAIDs.

Landmark studies include a retrospective study by Krawiec et al. (1990) that described the clinical features and treatment outcomes of prostatic abscesses in dogs, highlighting the importance of surgical drainage. Another study by White et al. (1997) evaluated the use of omentalization for prostatic abscesses, reporting a high success rate with minimal complications. A more recent study by Smith et al. (2015) compared different surgical techniques and found that partial prostatectomy and omentalization had similar outcomes, with lower morbidity than total prostatectomy. Consensus guidelines from the ACVS recommend that surgical drainage is the mainstay of treatment for prostatic abscesses, with antibiotics as an adjunct. The use of ultrasound-guided drainage has been reported but is associated with a higher recurrence rate. Overall, the evidence supports early surgical intervention and the use of omentalization as a safe and effective technique.